Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Michel A. Duchosal"'
Autor:
Alicia Rovó, Mathilde Gavillet, Beatrice Drexler, Peter Keller, Jenny Sarah Schneider, Giuseppe Colucci, Yan Beauverd, Hendrika Anette van Dorland, Matthias Pollak, Adrian Schmidt, Andrea De Gottardi, Marina Bissig, Thomas Lehmann, Michel A. Duchosal, Sacha Zeerleder
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
This national survey investigated the current practice in Switzerland by collecting participants' opinions on paroxysmal nocturnal hemoglobinuria (PNH) clone assessment and clinical practice.AimThis study aimed to investigate clinical indications pro
Externí odkaz:
https://doaj.org/article/7f17239ddf8b4137a4c5f47d99cc21e5
Autor:
Oussama ElMokh, Saki Matsumoto, Paulina Biniecka, Axel Bellotti, Karin Schaeuble, Francesco Piacente, Hector Gallart-Ayala, Julijana Ivanisevic, Ivan Stamenkovic, Alessio Nencioni, Aimable Nahimana, Michel A. Duchosal
Publikováno v:
Cell Death and Disease, Vol 13, Iss 4, Pp 1-9 (2022)
Externí odkaz:
https://doaj.org/article/f655c81b71b94683b6b1d9755f5a5853
Autor:
Paulina Biniecka, Saki Matsumoto, Axel Belotti, Jessie Joussot, Jian Fei Bai, Somi Reddy Majjigapu, Paul Thoueille, Dany Spaggiari, Vincent Desfontaine, Francesco Piacente, Santina Bruzzone, Michele Cea, Laurent A. Decosterd, Pierre Vogel, Alessio Nencioni, Michel A. Duchosal, Aimable Nahimana
Publikováno v:
Molecules, Vol 28, Iss 4, p 1897 (2023)
Targeting cancer cells that are highly dependent on the nicotinamide adenine dinucleotide (NAD+) metabolite is a promising therapeutic strategy. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme catalyzing NAD+ production. De
Externí odkaz:
https://doaj.org/article/a934d28d76cf415f8074ec99c1403245
Autor:
Moustafa S. Ghanem, Irene Caffa, Alberto Del Rio, Jorge Franco, Marco Daniele Parenti, Fiammetta Monacelli, Michele Cea, Amr Khalifa, Aimable Nahimana, Michel A. Duchosal, Silvia Ravera, Nadia Bertola, Santina Bruzzone, Alessio Nencioni, Francesco Piacente
Publikováno v:
Pharmaceuticals, Vol 15, Iss 7, p 848 (2022)
Depriving cancer cells of sufficient NAD levels, mainly through interfering with their NAD-producing capacity, has been conceived as a promising anti-cancer strategy. Numerous inhibitors of the NAD-producing enzyme, nicotinamide phosphoribosyltransfe
Externí odkaz:
https://doaj.org/article/d530f82977654c3b99de8a51175fb322
Autor:
Panagiotis Samaras, Mario Bargetzi, Daniel C. Betticher, Christoph Driessen, Michel A. Duchosal, Dominik Heim, Nicolas Ketterer, Erika Lerch, Thomas Matthes, Ulrich Mey, Thomas Pabst, Adrian Schmidt, Christian Taverna, Thilo Zander, Christoph Renner
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 1314 (2019)
This update on plasma cell myeloma has been elaborated by a Swiss expert panel as a result of the plethora of new data on the treatment of plasma cell myeloma reported recently. It adds new insights to the more extensive review that was published 3 y
Externí odkaz:
https://doaj.org/article/ccb3fc8bd12844b2b79bfe03d460b9cb
Autor:
Jakob R. Passweg, Helen Baldomero, Marc Ansari, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Jörg P. Halter, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müller, Gayathri Nair, Thomas Pabst, Christoph Renner, Adrian Schmidt, Georg Stussi, Grazia Nicoloso de Faveri, Urs Schanz, for the Swiss Blood Stem Cell Transplantation Group (SBST)
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 0910 (2018)
In 1997, the Swiss Blood Stem Cell Transplantation Group (SBST) initiated a mandatory national registry for all haematopoietic stem cell transplants (HCTs) in Switzerland. As of 2016, after 20 years, information was available for 7899 patients who ha
Externí odkaz:
https://doaj.org/article/c36c8bd0307b48e194437f606e771da4
Autor:
Maxime Pellegrin, Karima Bouzourène, Jean-François Aubert, Aimable Nahimana, Michel A. Duchosal, Lucia Mazzolai
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 9, p 2621 (2018)
Angiotensin (Ang) II triggers vulnerable atherosclerotic plaque development. Bone marrow (BM)-derived cells are key players in atherogenesis but whether Ang II induces plaque vulnerability directly through Ang II type 1 receptor (AT1R) activation on
Externí odkaz:
https://doaj.org/article/c90fe3eb5f844b4489558bf248fe59a5
Autor:
Jakob Passweg, Helen Baldomero, Mario Bargetzi, Christoph Bucher, Yves Chalandon, Michel A. Duchosal, Alois Gratwohl, Tayfun Güngör, Urs Hess, Kurt Leibundgut, Grazia Nicoloso de Faveri, Hulya Ozsahin, Thomas Pabst, Christoph Renner, Martin Stern, Georg Stussi, Urs Schanz, for the SBST (Swiss Blood Stem Cell Transplantation Group)
Publikováno v:
Swiss Medical Weekly, Vol 143, Iss 0708 (2013)
Haematopoietic stem cell transplantation (HSCT) is a highly specialised procedure used to treat malignancies of the lymphohaematopoietic system as well as some acquired and inherited disorders of the blood. This analysis by the Swiss Blood Stem Cell
Externí odkaz:
https://doaj.org/article/49ea8bc35cad4ff6a1462cc41ba3867d
Autor:
Mathilde Gavillet, Jasmine Noetzli, Sabine Blum, Michel A. Duchosal, Olivier Spertini, Jean-Francois Lambert
Publikováno v:
Haematologica, Vol 97, Iss 12 (2012)
Externí odkaz:
https://doaj.org/article/c24911480ad449239024ce18e54bc26a
Autor:
Joanna Drozd-Sokolowska, Luuk Gras, Nienke Zinger, Jorge Sierra, Montserrat Rovira, Urpu Salmenniemi, Teresa Zudaire, Arancha Bermúdez, Goda Choi, Matthew P. Collin, Martin Kaufmann, Piotr Kozlowski, Xavier Poiré, Josep-Maria Ribera, Antonia Sampol, Keith Wilson, Michel A. Duchosal, Tobias Gedde-Dahl, Eric Deconinck, Milena Mirabile, Kavita Raj, Michel Van Gelder, Olivier Tournilhac, Donal P. McLornan, Ibrahim Yakoub-Agha
Publikováno v:
Blood. 140:4848-4850
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07e3bef9da5d6d0be3f86270299c29ea
https://doi.org/10.1182/blood-2022-166166
https://doi.org/10.1182/blood-2022-166166